Michael serves as a primary research and analytical resource for Innovations and its partners with a focus on market assessment of new medical technologies. Prior to joining the Clinic, he spent more than 11 years at Health Research International, an independent medical market research and consulting firm, most recently as Vice President. This experience entailed working closely with a broad range of medical technology firms from local start-ups to multinationals. Michael earned a BA in business administration (cum laude, Marketing major) from the Richard T. Farmer School of Business at Miami University.
Susan Bernat is the General Manager of Strategic Marketing for Cleveland Clinic Innovations. In this capacity, Susan oversees the strategic planning, development and implementation of marketing and communications initiatives for CCI. Susan is also responsible for the vision and execution of the annual Medical Innovation Summit. Prior to assuming this role in January 2014, Susan was the Director, Operations & Finance for CCI since November 2004. She was responsible for all fiduciary management including fiscal planning and other related financial activities. Susan also assists with establishing and implementing strategic goals and oversees long-range facilities planning. She served as the Director of Finance for the GCIC with responsibilities including development and implementation of strategy for ensuring financing of the GCIC consortium operations and management of financial performance and budgets. Prior to joining CCI, she was responsible for budget and contract negotiations within cardiology research at Cleveland Clinic. She received her undergraduate degree in Accounting from Kent State University, and an MBA from Cleveland State University.
Marwane Berrada has over 13 years of experience in medical device product development and commercialization. Prior to joining CCI, Marwane was Managing Director at Bavaria Medical Technology, a product development company. In addition, Marwane has held various engineering, managerial, and executive management positions in companies such Microvena, ev3, CryoCath Technologies, Vascular NanoTransfer and OligoMedic. Product expertise has been in percutaneous therapies such as electrophysiology, structural heart, cardiovascular and endovascular devices, in addition to product commercialization of orthopedic implants. Through his engineering and business backgrounds, Marwane is experienced in leading both traditional and virtual R&D teams throughout the entire development life-cycle including US and European regulatory tracks. He’s also listed in 8 patents.
Marwane received his BS and MS in Mechanical Engineering from the University of Minnesota and an MBA in Finance from McGill University.
Dae Capobianco has over 8 years of experience in medical device sales and marketing. Prior to joining CCI, Dae was a Senior Clinical Specialist at Medtronic Inc. Her work centered on providing healthcare professionals and patients clinical, technical, and educational training and support on life-saving medical technologies within the Cardiac Rhythm Disease Management Division as well as managing and developing customer relationships in accounts such as Cleveland Clinic. Additionally, she led continuing education for nurses as a program manager and speaker, cross-trained to perform research in company sponsored clinical trials, and was a proactive committee member in the development and design of corporate customer education and training.
Dae received her BSE in Biomedical Engineering with a concentration in polymeric materials and her MBA with a focus in healthcare, project management, and entrepreneurship from Case Western Reserve University.
Veronika’s function serves as liaison and administrative, technical, and operational resource for the Global Cardiovascular Innovation Center team. She has an extensive background providing support to senior-level Executives and world class service to all valued customers.
Kelly B. Emerton, PhD, joins the GCIC team as Sr. Director of Product Development, lending her medical device industry experience towards the GCIC mission of developing and commercializing cardiovascular technology. Prior to joining the GCIC team , she spent 6+ years across Medtronic business units (Spine and Endovascular Therapy divisions) leading multiple major development programs with cross-functional execution. Her background includes US and outside US regulatory approvals for Class III implantable and combination-product devices for orthopedic and endovascular therapy indications. During her Endovascular Therapy tenure, she was responsible for leading multiple pipeline programs within the thoracic aortic product portfolio.
Kelly received a BSE degree in Biomedical Engineering from Michigan Technological University, and an MS and PhD in Biomedical Engineering from City College at the City University of New York.
As a member of the Commercialization team, Kaleigh is the initial point of contact for Cleveland Clinic inventors who are considering the commercial potential of their inventions. In her current role, she advises inventors on the commercialization process and connects them with available resources. She works collaboratively with the Innovations team in the identification, marketing and commercialization of healthcare technologies. Kaleigh joins CCI with management experience in medical device sales. She received her BBA in Marketing, with a minor in Entrepreneurship, from the Richard T. Farmer School of Business at Miami University.
Mark Low comes to GCIC with a career of building successful programs to introduce new concepts and new modalities to new markets. He has managed all facets of product and market development spanning diagnostic and interventional cardiology, interventional radiology and neuroradiology, stroke treatment, image-guided surgery, drug delivery and oncology. He has served on the senior management team of TomTec Imaging Systems, Image Guided Technologies, EKOS Corporation, and Sonus Pharmaceuticals.
Prior to concentrating his focus on start-up ventures and early stage market development, Mr. Low held progressively more responsible and trailblazing positions in marketing and business development for Hewlett-Packard's Medical Products Group. Specializing in cardiovascular ultrasound, Mr. Low managed high performance cardiac diagnostic systems, introduced products to new market segments including private office and interventional cardiology, and developed new applications including 3D and stress echocardiography, and catheter-based intravascular ultrasound. In conjunction with these programs Mr. Low managed strategic relationships with various corporate partners, investors, universities, inventors, clinical investigators and manufacturers. Mr. Low received a B.A. degree in Natural Science from Johns Hopkins University, an M.S. degree in Physiology from the Medical College of Wisconsin, and an M.S. degree in Technical Communication from Rensselaer Polytechnic Institute.
Matt McBride has been with the Innovations group since 2012, focusing on the assessment, commercialization, and business development behind medical break-throughs at the Cleveland Clinic. Prior to joining CCI, Matt served as a Naval Officer at several commands throughout the world. As a Naval Officer he served as Executive Officer of the Military Sealift Command in Diego Garcia, Program Manager for the V-22 Osprey in Philadelphia, and as the Contract Administrator for Forward Operating Base, Camp Leatherneck, in Afghanistan.
Matt received a BS in political science with a focus on engineering, math and science in 2006, from the United States Naval Academy. Matt is currently pursuing his Executive MBA at Case Western Reserve University (2015).
Sonja O'Malley has over 20 years of experience in healthcare information technology. Prior to joining CCI, Sonja was responsible for managing the global life sciences client portfolio at Axentis. Axentis, a Wolters Kluwer business, is a software provider of on-demand solutions used by life science customers and other highly regulated industries to minimize their exposure to risk and optimize business performance; a $5 billion (2010) company with 19,000 employees worldwide. Sonja's work has spanned clinical laboratory medicine as a MT (ASCP), consulting in the health care practice of Andersen Consulting, directing the process improvement practice within a health insurance organization, and building multiple startups as an early employee.
Sonja is a certified PMP from the Project Management Institute and has a BS in medical technology from Miami University and an MBA from the Weatherhead School of Management at Case Western Reserve University.
Pete O'Neill is the Interim Executive Director of Cleveland Clinic Innovations. Pete has 10+ years of experience at CCI. Prior to joining CCI, Pete held positions as Deputy Director of the Great Lakes Industrial Technology Commercialization Center, and product engineer at PCC Airfoils. He received his BS in aeronautical engineering from MIT.
Jason Ospina has over 10 years of experience in Life Sciences and over 2 years of experience in technology commercialization. Prior to joining CCI, Jason was a post-doctoral fellow at Cleveland Clinic's Lerner Research Institute. His research centered on the delineation of mechanisms regulating Hedgehog signal transduction and the influence of protein phosphorylation on pathway outcomes.
Jason received his PhD in genetics from Case Western Reserve University, where his thesis work examined nuclear protein dynamics and transport, as well as ribonucleoprotein biogenesis.
Marcie has over 10 years of experience in medical device product development and commercialization. Prior to joining CCI, Marcie held several product development positions at Kensey Nash Corporation in the fields of interventional cardiology and soft tissue repair, concluding as a Senior Biomaterials Engineer.
Marcie received her BS and MS in materials engineering from Drexel University.
Joseph T. Rich, JD, MBA is responsible for new venture development and growth, and manages the relationships between the boards and executive teams of CCI and OBVF portfolio companies. He also is the Portfolio Manager of the Ohio Third Frontier sponsored, $30 million+ Ohio BioValidation Funds early stage investment program. He has extensive business development expertise through his involvement in the organization and start-up of numerous financially successful companies. Mr. Rich possesses industry-specific expertise in life sciences, venture capital investments and angel financing, joint ventures and other strategic alliances involving technology commercialization. He has led many OBVF deal teams that resulted in successful OBVF investments. Mr. Rich serves as a Board Member and or Corporate Officer for over 15 early-stage companies, and led the successful exit of portfolio company FlexLife to LifeWatch Services, Inc. He has a decade of technology commercialization experience, previously serving as a senior member of Cleveland Clinic’s New Venture group. Prior to Cleveland Clinic, he served as vice president and general counsel for The University of Akron Research Foundation, where he was instrumental in numerous corporate ventures and international deals. He is actively involved in higher education in the State of Ohio, and has served on the Board of Trustees of The University of Akron after an appointment by the Ohio governor. Mr. Rich received a BS in Biology from John Carroll University, an MBA in Finance from The University of Akron and a JD from The University of Akron.
Dhanesh Shah has over 6 years of experience in healthcare corporate finance, strategy and business development. Prior to joining CCI, Dhanesh worked in Division of Finance at Cleveland Clinic, overseeing Clinic’s debt capital portfolio. A strong background in economics and accounting, his past experience has been with financial services organizations focused on structured products ratings and financial auditing.
Dhanesh has received a BA in economics/accounting and his MS in accounting/taxation from University of Mumbai. He received an MBA from Case Western Reserve University.
Sarah is the General Manager of Operations & Administration and is responsibile for all work pertaining to financial, administrative, and human resources activities of Cleveland Clinic Innovations. Sarah has over 20 years in healthcare and is recognized for her expertise in practice management and strategic and business planning. Prior to rejoining CCF, Sarah worked as a Consultant at The Gateway Group, Vice President of Medical Operations at The MetroHealth System, and as an Administrator at CCF. Her work centered on directing and managing medical group practices, developing and executing strategic initiatives, front end revenue enhancement and improving the performance of existing product lines.
Sarah received her BS in business administration degree from John Carroll University and her MBA from Cleveland State University.
Charles Steiner has over 25 years of experience in medical technology development. Prior to joining CCI, Charles was a product development engineer for the Center for Neurological Restoration and a business and technology developer for the Center for Minimally Invasive Surgery at Cleveland Clinic. His contributions have been in the field of surgical navigation for cranial and spinal indications, neuromodulation for movement and cognitive indications as well as neuromodulation for headache and autonomic indications.
Charles received his BS in chemistry and computer science from Case Western Reserve University.
Prior to joining the GCIC, Tom served as Executive Director of the Chamber of Commerce in Beachwood where he coordinated economic development efforts for the city. During his tenure, he helped more than 20 international companies establish their North America headquarters in Beachwood. Tom is committed to the Northeast Ohio community, having served as chair of the Northern Ohio Area Chambers of Commerce (NOACC). He is also a frequent guest columnist in publications such as Crain’s Cleveland Business, Inside Business and the Cleveland Jewish News. For his outstanding work, he has been recognized with awards from many economic development and community organizations. Tom was the Principal of TNS & Associates and prior to that served as a senior staff for academic institutions and social service organizations.
Tom received his BA from Kent State University and his MSW from the Wurzweiler School of Social Work.
216-621-2234 ext. 110
Michael has over 10 years of experience in medical device marketing. Prior to joining CCI, Michael was a Senior Product Manager at Integra Lifesciences. His work centered on commercializing spine and neurosurgical related technologies. Michael received his BS in electrical engineering from Villanova University and his MBA from Case Western Reserve University.
Jim is General Manager, Internal Business Development at Cleveland Clinic Innovations. Jim identifies business opportunities within Cleveland Clinic while working with outside entities on a variety of advisory services offered by CCI. These services include identifying outside people/organizations in their early stages and working with them to address their organization’s needs as they progress through their incubation on their early commercial operations period. Service offerings include business diagnostics, market segmentation, introduction to the healthcare financial ecosystem, key opinion leader and subject matter expertise introduction and other services needed by early stage organizations. Jim has over 20 years of experience in healthcare operations and consulting services. Prior to joining CCI, Jim was the Institute Administrator for the Cleveland Clinic’s Orthopaedic and Rheumatologic Institute and Director of the Cleveland Clinic Innovation’s Enterprise Solutions team. His work centered on monetizing workflows, trade secrets and non-IP protectable solutions. Jim has also worked at finding solutions and introducing partners centered around healthcare solutions.
Jim received his BSBA in Finance from John Carroll University. He has an MBA from Cleveland State University and has his Series 6 and 63 securities license.
Matt has over 7 years of writing and marketing experience. As a Business Associate of the Technology & Communications group, Matt develops content for all internal and external marketing and communications, supports all branding efforts, and helps to plan, promote and produce the Cleveland Clinic's Medical Innovation Summit. Prior to joining CCI, Matt was a Grant Writer for LNE Group, where he consulted on funding opportunities for clients in healthcare, renewable energy, and manufacturing industries.
Matt received his BA in English from the University of Notre Dame.
Innovations has facilitated several Cleveland Clinic Spin-Offs over the last decade. Click here to see our current portfolio.
The Alliance network strives to realize new opportunities for innovation by gaining a 360-degree perspective on healthcare and its future.
Cleveland Clinic © 2016